» Articles » PMID: 18054552

Glucose-dependent Insulinotropic Polypeptide Enhances Adipocyte Development and Glucose Uptake in Part Through Akt Activation

Overview
Specialty Gastroenterology
Date 2007 Dec 7
PMID 18054552
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: In addition to its role as the primary mediator of the enteroinsular axis, glucose-dependent insulinotropic polypeptide (GIP) may play a critical role in the development of obesity. The purpose of these studies was to characterize the effects of GIP and its receptor (GIPR) in adipocyte development and signaling.

Methods: Effects of GIP and GIPR on differentiated 3T3-L1 cells were analyzed using Western blot analysis, Oil-Red-O staining, cyclic adenosine monophosphate radioimmunoassay, immunofluorescence microscopy, and glucose uptake measurements.

Results: To determine whether GIP and GIPR are important components in adipocyte development, the expression profile of GIPR during differentiation was examined. GIPR protein expression was enhanced during the differentiation process, and coincubation with its ligand GIP augmented the expression of aP2, a fat cell marker. Conversely, the suppression of GIPR expression by a specific short hairpin RNA attenuated Oil-Red-O staining and aP2 expression, suggesting that the GIPR may play a critical role in adipocyte development. To investigate specific signaling components that may mediate the effects of GIP, we analyzed Akt, glucose transporter-4, and glucose uptake, all of which are modulated by insulin in fat cells. Like insulin, GIP induced the activation of Akt in a concentration-dependent manner, promoted membrane glucose transporter-4 accumulation, and enhanced [(3)H]-2-deoxyglucose uptake.

Conclusions: These studies provide further evidence for an important physiologic role for GIP in lipid homeostasis and possibly in the pathogenesis of obesity. Furthermore, our data indicate that the GIPR might represent a suitable target for the treatment of obesity.

Citing Articles

The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice.

Yu X, Chen S, Funcke J, Straub L, Pirro V, Emont M Cell Metab. 2024; 37(1):187-204.e7.

PMID: 39642881 PMC: 11711001. DOI: 10.1016/j.cmet.2024.11.003.


Tirzepatide, GIP(1-42) and GIP(1-30) display unique signaling profiles at two common GIP receptor variants, E354 and Q354.

Rees T, Buttle B, Tasma Z, Yang S, Harris P, Walker C Front Pharmacol. 2024; 15:1463313.

PMID: 39464637 PMC: 11502443. DOI: 10.3389/fphar.2024.1463313.


Initial clinical manifestations in a young male with -variant-associated diabetes.

Akiba K, Zukeran H, Hasegawa Y, Fukami M Clin Pediatr Endocrinol. 2024; 33(4):224-228.

PMID: 39359667 PMC: 11442700. DOI: 10.1297/cpe.2024-0016.


Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance.

De Fano M, Malara M, Vermigli C, Murdolo G Int J Mol Sci. 2024; 25(16).

PMID: 39201336 PMC: 11354636. DOI: 10.3390/ijms25168650.


Transforming obesity: The advancement of multi-receptor drugs.

Kusminski C, Perez-Tilve D, Muller T, DiMarchi R, Tschop M, Scherer P Cell. 2024; 187(15):3829-3853.

PMID: 39059360 PMC: 11286204. DOI: 10.1016/j.cell.2024.06.003.


References
1.
Nugent C, Prins J, Whitehead J, Wentworth J, Chatterjee V, ORahilly S . Arachidonic acid stimulates glucose uptake in 3T3-L1 adipocytes by increasing GLUT1 and GLUT4 levels at the plasma membrane. Evidence for involvement of lipoxygenase metabolites and peroxisome proliferator-activated receptor gamma. J Biol Chem. 2001; 276(12):9149-57. DOI: 10.1074/jbc.M009817200. View

2.
Trumper A, Trumper K, Horsch D . Mechanisms of mitogenic and anti-apoptotic signaling by glucose-dependent insulinotropic polypeptide in beta(INS-1)-cells. J Endocrinol. 2002; 174(2):233-46. DOI: 10.1677/joe.0.1740233. View

3.
White M, Maron R, Kahn C . Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells. Nature. 1985; 318(6042):183-6. DOI: 10.1038/318183a0. View

4.
Szecowka J, Grill V, Sandberg E, Efendic S . Effect of GIP on the secretion of insulin and somatostatin and the accumulation of cyclic AMP in vitro in the rat. Acta Endocrinol (Copenh). 1982; 99(3):416-21. DOI: 10.1530/acta.0.0990416. View

5.
Flatt P, Bailey C, Kwasowski P, Page T, Marks V . Plasma immunoreactive gastric inhibitory polypeptide in obese hyperglycaemic (ob/ob) mice. J Endocrinol. 1984; 101(3):249-56. DOI: 10.1677/joe.0.1010249. View